Literature DB >> 24374294

From the CUPIC study: great times are not coming(?).

Daniel Schmidt-Martin1, Diarmaid Houlihan2, Aidan McCormick2.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24374294     DOI： 10.1016/j.jhep.2013.11.035

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  1 in total

1.  Favorable adverse event profile of sofosbuvir/ribavirin compared to boceprevir/interferon/ribavirin for treatment of hepatitis C.

Authors:  Shivakumar Narayanan; Kerry Townsend; Thomas Macharia; Adrian Majid; Amy Nelson; Robert R Redfield; Shyam Kottilil; Rohit Talwani; Anu Osinusi
Journal:  Hepatol Int       Date:  2014-09-21       Impact factor: 9.029
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.